Why UnitedHealth Group Stock Lost 17% in December
Shares of UnitedHealth Group (NYSE: UNH) were pulling back in December due to a backlash against the company following the murder of one of its executives and reports of a potential crackdown on pharmacy benefit managers (PBMs), including UnitedHealth's OptumRx.
Other media reports also shone a harsh light on the business and could lead to more regulation or an overhaul of some healthcare industry practices.
According to data from S&P Global Market Intelligence, the stock lost 17% last month. As you can see from the chart, the stock fell in three stages over the first half of December, and then traded sideways for the rest of the month.
Source Fool.com
UnitedHealth Group Inc. Stock
€282.60
-0.630%
With 72 Buy predictions and 2 Sell predictions UnitedHealth Group Inc. is one of the favorites of our community.
With a target price of 350 € there is a positive potential of 23.85% for UnitedHealth Group Inc. compared to the current price of 282.6 €.
